Allred Capital Management, LLC Aytu Biopharma, Inc Transaction History

Allred Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.15 - $4.0 $3,000 - $80,000	20,000 Added 19.05%	125,000 $23,000
Q3 2022 Oct 27, 2022	BUY	$0.19 - $3.8 $16,788 - $335,775	88,362 Added 531.09%	105,000 $19,000
Q2 2022 Aug 09, 2022	BUY	$0.46 - $1.08 $7,653 - $17,969	16,638 New	16,638 $11,000
Q2 2021 Aug 05, 2021	SELL	$4.73 - $7.56 $12,860 - $20,555	-2,719 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$6.23 - $9.88 $16,939 - $26,863	2,719 New	2,719 $20,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $88.7M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Allred Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Allred Capital Management, LLC with notifications on news.